Life sciences leaders unite to condemn radical plans to rewrite medicines scheme

ABPI

9 October 2023 - Over twenty industry leaders from companies supplying the NHS with essential medicines warn that radical plans to change the Statutory Scheme for branded medicines are unworkable. 

If implemented, the industry believes the measures will be highly damaging to UK life sciences and NHS patients’ access to medicines.

Read ABPI press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Medicine , Regulation , Pricing